Events Partner Content SMi's 10th Annual RNA Therapeutics Returns this February 201... RNA Therapeutics 2019
Partner Content Partner Content The 10th Annual RNA Therapeutics Returns to London this Feb! RNA Therapeutics
R&D GSK signs $300m R&D deal with 23andMe GlaxoSmithKline signed a $300 million research and development deal with mail gene profiling company 23andMe, gaining access to four million customers DNA information.
Partner Content Partner Content Explore the latest developments in ATMPs at Cell & Gene ... Cell and Gene Therapy 2018
Partner Content Partner Content Attendee List Released for SMi’s 9th Annual RNA Therapeutics RNA Therapeutics
Partner Content Partner Content RNA Therapeutics conference will take place in just 4 weeks! 4 Weeks Until RNA Therapeutics
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends